CONTINUING MEDICAL EDUCATION (CME) QUESTIONS|
        November 21, 2024
    Ven-Aza outcomes in AML by genetic risk Free
                    
                        CME
                    
        
Blood (2024) 144 (21): 2271.
        Connected Content
                            
                        A related article has been published: 
                                                                Genetic risk stratification and outcomes among treatment-naive patients with AML treated with venetoclax and azacitidine
                
            
        Citation
  Ven-Aza outcomes in AML by genetic risk. Blood 2024; 144 (21): 2271. doi: https://doi.org/10.1182/blood.2024027149
Download citation file: